✦ LIBER ✦

A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir

✍ Scribed by Minghao Ha; Guotong Zhang; Shu Diao; Mingfang Lin; Liping Sun; Huiyuan She; Chenbao Kuan; Lihui Shen; Chunhong Huang; Wenjuan Shen; Zhongming Huang

Book ID: 106212027
Publisher: Springer Vienna
Year: 2011
Tongue: English
Weight: 179 KB
Volume: 157
Category: Article
ISSN: 1432-8798
DOI: 10.1007/s00705-011-1163-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poor durability of lamivudine effectiven

Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients

✍ Feng Liu; Lei Wang; Xiao Ying Li; You De Liu; Jing Bo Wang; Zhao Hua Zhang; Yao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

Stringent cessation criterion results in

Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients

✍ L. Wang; F. Liu; Y.-D. Liu; X.-Y. Li; J.-B. Wang; Z.-H. Zhang; Y.-Z. Wang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Adefovir dipivoxil added to ongoing lami

Adefovir dipivoxil added to ongoing lamivudine therapy in patients with lamivudine-resistant hepatitis B e antigen-negative chronic hepatitis B

✍ T. Vassiliadis; N. Nikolaidis; O. Giouleme; K. Tziomalos; N. Grammatikos; K. Pat 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Early hepatitis B virus DNA reduction in

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

✍ Nancy Leung; Cheng-Yuan Peng; Hie-Won Hann; Jose Sollano; Judy Lao-Tan; Chao-Wei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naïve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naïve CHB patients with baseline HBV DNA of 10(8) copi

Long-term therapy with adefovir dipivoxi

Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine

✍ S. MANOLAKOPOULOS; S. BETHANIS; S. KOUTSOUNAS; J. GOULIS; J. VLACHOGIANNAKOS; E. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

Pretherapy alanine transaminase level as

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B

✍ Rong-Nan Chien; Yun-Fan Liaw; Mark Atkins 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views